By InvitationNot Applicable

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

Netherlands400 participantsStarted 2023-09-28

Plain-language summary

The goal of this observational study is to investigate the incidence, current management practices, and outcomes in pediatric patients with HAC after liver transplantation. Research question: * What are the overall incidence of HAC and the effectiveness of all treatment strategies for HAC after pediatric LT? * What are the current management practices in the experience of centers, anticoagulant therapy, screening protocol, and assessment criteria for HAC after pediatric LT? The burden of participation is considered to be minimal, and limited to the questionnaires.

Who can participate

Age range0 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Liver transplantation between January 1st 2002 and January 1st 2022, diagnoses of HAC after LT * The age of the patient is below 18 years at the time of diagnosis and intervention * The date of diagnosis of HAC or intervention was before January 1st 2023. HAC occurring after first or subsequent LTs are included. Exclusion criteria: N/A

What they're measuring

Graft survival

Timeframe: 1-1-2001 and 1-1-2023

Patient survival

Timeframe: 1-1-2001 and 1-1-2023

Trial details

NCT IDNCT05818644

SponsorUniversity Medical Center Groningen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12

View on ClinicalTrials.gov More Hepatic Artery Thrombosis trials